Global Organ Preservation and Perfusion Solution Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Organ Preservation and Perfusion Solution Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Organ preservation and perfusion solutions are specialized solutions used to maintain the viability and function of organs during transplantation or storage for medical purposes. These solutions are designed to provide optimal conditions for the preservation and transportation of organs from the donor to the recipient, ensuring minimal damage and maximizing the chances of a successful transplant.
Organ Preservation and Perfusion Solution report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Organ Preservation and Perfusion Solution market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Kidney and Liver are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Organ Preservation and Perfusion Solution industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Organ Preservation and Perfusion Solution key companies include 21st Century Medicine, Bridge to Life Limited, BioLife Solutions, Dr. Franz Köhler Chemie GmbH, XVIVO Perfusion, Artivion, Preservation Solutions, Bristol Myers Squibb and Teva Pharmaceuticals, etc. 21st Century Medicine, Bridge to Life Limited, BioLife Solutions are top 3 players and held % share in total in 2022.
Organ Preservation and Perfusion Solution can be divided into Static Cold Storage (SCS), Hypothermic Perfusion Preservation (HPP), Hypothermic Machine Preservation (HMP) and Others, etc. Static Cold Storage (SCS) is the mainstream product in the market, accounting for % share globally in 2022.
Organ Preservation and Perfusion Solution is widely used in various fields, such as Kidney, Liver, Heart and Lung, etc. Kidney provides greatest supports to the Organ Preservation and Perfusion Solution industry development. In 2022, global % share of Organ Preservation and Perfusion Solution went into Kidney filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Organ Preservation and Perfusion Solution market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
21st Century Medicine
Bridge to Life Limited
BioLife Solutions
Dr. Franz Köhler Chemie GmbH
XVIVO Perfusion
Artivion
Preservation Solutions
Bristol Myers Squibb
Teva Pharmaceuticals
Lifeline Scientific
Advanced Life Solutions
Organ Recovery Systems
Transmedics
Accord Healthcare
Segment by Type
Static Cold Storage (SCS)
Hypothermic Perfusion Preservation (HPP)
Hypothermic Machine Preservation (HMP)
Others
Kidney
Liver
Heart
Lung
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Organ Preservation and Perfusion Solution market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Organ Preservation and Perfusion Solution introduction, etc. Organ Preservation and Perfusion Solution Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Organ Preservation and Perfusion Solution market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Organ Preservation and Perfusion Solution report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Organ Preservation and Perfusion Solution market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Kidney and Liver are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Organ Preservation and Perfusion Solution industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Organ Preservation and Perfusion Solution key companies include 21st Century Medicine, Bridge to Life Limited, BioLife Solutions, Dr. Franz Köhler Chemie GmbH, XVIVO Perfusion, Artivion, Preservation Solutions, Bristol Myers Squibb and Teva Pharmaceuticals, etc. 21st Century Medicine, Bridge to Life Limited, BioLife Solutions are top 3 players and held % share in total in 2022.
Organ Preservation and Perfusion Solution can be divided into Static Cold Storage (SCS), Hypothermic Perfusion Preservation (HPP), Hypothermic Machine Preservation (HMP) and Others, etc. Static Cold Storage (SCS) is the mainstream product in the market, accounting for % share globally in 2022.
Organ Preservation and Perfusion Solution is widely used in various fields, such as Kidney, Liver, Heart and Lung, etc. Kidney provides greatest supports to the Organ Preservation and Perfusion Solution industry development. In 2022, global % share of Organ Preservation and Perfusion Solution went into Kidney filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Organ Preservation and Perfusion Solution market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
21st Century Medicine
Bridge to Life Limited
BioLife Solutions
Dr. Franz Köhler Chemie GmbH
XVIVO Perfusion
Artivion
Preservation Solutions
Bristol Myers Squibb
Teva Pharmaceuticals
Lifeline Scientific
Advanced Life Solutions
Organ Recovery Systems
Transmedics
Accord Healthcare
Segment by Type
Static Cold Storage (SCS)
Hypothermic Perfusion Preservation (HPP)
Hypothermic Machine Preservation (HMP)
Others
Segment by Application
Kidney
Liver
Heart
Lung
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Organ Preservation and Perfusion Solution market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Organ Preservation and Perfusion Solution introduction, etc. Organ Preservation and Perfusion Solution Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Organ Preservation and Perfusion Solution market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.